Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA

NCT: NCT06086873 · RECRUITING

NCT IDNCT06086873
StatusRECRUITING
Start Date2023-09-05
Completion2027-03-31

Brief Summary

This study aims to characterise the stability of crestal bone levels one year after loading, the associated aesthetic outcomes, immunological response, prosthodontic outcomes as well as overall patient reported outcome measures for modSLA (SLActive, Institut Straumann AG, Switzerland) and NGA (TiUltraNP, Nobel Biocare AG, Switzerland) dental implants.

Frequently Asked Questions

What is Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA?

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA is a clinical trial registered under NCT06086873. Current status: RECRUITING.

What is the status of NCT06086873?

The current status of NCT06086873 (Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA) is: RECRUITING.

When did Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA start?

Investigating Implant Surface Effect on Osseointegration: NGA vs. ModSLA started on 2023-09-05.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑